Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Axonics, Inc. (AXNX)

48.54   -1.11 (-2.24%) 05-26 16:00
Open: 48.44 Pre. Close: 49.65
High: 50.34 Low: 48.38
Volume: 532,148 Market Cap: 2,446(M)

Technical analysis

as of: 2023-05-26 4:21:35 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 65.89     One year: 71.7
Support: Support1: 48.38    Support2: 40.25
Resistance: Resistance1: 56.42    Resistance2: 61.38
Pivot: 52.79
Moving Average: MA(5): 50.26     MA(20): 53.14
MA(100): 57.17     MA(250): 62.2
MACD: MACD(12,26): -1.8     Signal(9): -1.3
Stochastic oscillator: %K(14,3): 7.9     %D(3): 12.3
RSI: RSI(14): 34
52-week: High: 79.91  Low: 46.56
Average Vol(K): 3-Month: 628 (K)  10-Days: 541 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ AXNX ] has closed above bottom band by 4.6%. Bollinger Bands are 10.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 50.4 - 50.81 50.81 - 51.08
Low: 47.54 - 47.99 47.99 - 48.29
Close: 47.96 - 48.65 48.65 - 49.11

Company Description

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Headline News

Thu, 25 May 2023
'We're Going Up': Billionaire Steve Cohen Loads Up on These 2 ... - Nasdaq

Mon, 22 May 2023
Sectoral Asset Management Inc. Sells 26650 Shares of Axonics, Inc ... - MarketBeat

Tue, 16 May 2023
Russell Investments Group Ltd. Sells 20301 Shares of Axonics, Inc ... - MarketBeat

Mon, 15 May 2023
What Makes Axonics (AXNX) Unique? - Yahoo Finance

Fri, 12 May 2023
Axonics: Attractive Strong Growth Profile (NASDAQ:AXNX) - Seeking Alpha

Mon, 08 May 2023
When Will Axonics, Inc. (NASDAQ:AXNX) Become Profitable? - Simply Wall St

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 50 (M)
Shares Float 50 (M)
% Held by Insiders 0.8 (%)
% Held by Institutions 103.2 (%)
Shares Short 4,120 (K)
Shares Short P.Month 4,050 (K)

Stock Financials

EPS -0.94
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 11.51
Profit Margin (%) -15.7
Operating Margin (%) -10.6
Return on Assets (ttm) -3.3
Return on Equity (ttm) -8.9
Qtrly Rev. Growth 45.9
Gross Profit (p.s.) 3.92
Sales Per Share 5.87
EBITDA (p.s.) -0.4
Qtrly Earnings Growth 0
Operating Cash Flow 12 (M)
Levered Free Cash Flow 47 (M)

Stock Valuations

PE Ratio -51.64
PEG Ratio -2
Price to Book value 4.21
Price to Sales 8.26
Price to Cash Flow 211.17

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.